Newcore’s wide gold hit boosts Enchi plan in Ghana

Newcore Gold filed an NI 43-101 technical report for the Enchi Gold Project in Ghana supporting a pre-feasibility study effective June 23, 2026. The base case targets a conventional open pit with 5.5 million tonnes per annum and carbon-in-leach processing using contract mining. The PFS is based on a March 18, 2026 resource estimate and excludes over 50,000 metres of ongoing drilling.

AT&T stock fell 5% after reports that SpaceX is negotiating for access to 80,000 U.S. cell sites, raising competition concerns. This follows AT&T's Q3 2026 earnings, which included a $2.6B impairment charge, increased debt to $149.8B, and softer phone net additions. Analysts cut price targets, with Morgan Stanley at $25 and Barclays at $21. Peers Verizon and T-Mobile also declined, while tower companies Crown Castle and American Tower rose.

Moderna (MRNA) stock fell 2% on Friday, extending a 17% drop from Thursday, after leaked data from a late-stage melanoma vaccine trial disappointed investors. The trial was conducted with Merck (MRK). Goldman Sachs (GS) raised its target to $137, while Morgan Stanley (MS) and Citi (C) maintain Neutral and Sell ratings, respectively. The stock is down from $200 despite positive Phase 3 results in August.

SpaceX's reported plans to access 80,000 U.S. cell sites caused shares of T-Mobile (TMUS), AT&T (T), and Verizon (VZ) to fall 5%, 4%, and 3% respectively. SpaceX aims to become a fourth nationwide wireless carrier, leveraging its Starlink satellite network. AT&T and Verizon executives downplayed the threat, citing technical and scale challenges. The Communication Services Select Sector SPDR ETF (XLC) declined 1%.

Nokia's stock (NOK) rose 4.3% after multiple analyst upgrades, including from Handelsbanken and OP Corporate Bank, citing an overreaction to its Q3 2026 earnings report. Despite beating estimates, concerns over free cash flow and restructuring charges caused a prior-day selloff. The stock is technically oversold, with a one-month decline of 26%. AI & Cloud net sales surged 123% year-over-year, and comparable operating profit rose 35%.

Bloom Energy (BE) stock fell 12% in morning trading, extending a post-earnings selloff despite beating Q3 2026 revenue ($1.24B) and EPS ($0.94) estimates. Concerns over negative free cash flow ($181M) and high P/E (315x) weighed on shares. Analysts remain divided, with Mizuho reiterating an Outperform rating and BMO maintaining a Hold. Broader market declines also contributed to the drop.